{"database": "lobbying", "table": "lobbying_activities", "rows": [[2140081, "e1d5e7b3-09cd-4275-91c1-67c5c64f6047", "Q2", "MR. BRIAN KELLY", 40024191, "INTELLIA THERAPEUTICS", 2018, "second_quarter", "MED", "Gene Editing", "Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office", 15000, null, 0, 0, "2018-07-03T11:36:05.550000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2140081"], "units": {}, "query_ms": 77.03865098301321, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}